SCHEMBL27593153

SCHEMBL27593153

CCCN(CCC)C(=O)c1cc(CCBr)cc(C(=O)OCC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.42
CYP4A11 Q02928 2/20 0.42
CA12 O43570 3/20 0.42
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA7 P43166 3/20 0.42
CA9 Q16790 3/20 0.42
CA14 Q9ULX7 3/20 0.42
CTSD P07339 1/20 0.41
BACE1 P56817 1/20 0.41
DRD2 P14416 1/20 0.39
DRD3 P35462 1/20 0.39
CYP2C19 P33261 2/20 0.38
MEP1B Q16820 1/20 0.38
CYP2C9 P11712 1/20 0.38
TP53 P04637 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3348484 0.89 CA12 (0.44) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL3353303 0.85 PRKCA (0.46) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL3348692 0.81 CTSD (0.43) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL27593155 0.80 CA12 (0.43) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL6617310 0.80 CA12 (0.51) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL6618564 0.79 CA12 (0.50) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL14341681 0.76 CA12 (0.58) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL5155516 0.76 CYP4F2 (0.45) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL3349941 0.75 KDM4E (0.46) CYP4F2CYP4A11CA12CA1CA2
SCHEMBL3854418 0.74 CA12 (0.51) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100366605-C Compounds to treat alzheimer's disease ELAN PHARM INC (US) 2008-02-06 CN disclosed
CN-101090883-A Substituted hydroxyethylamines ELAN PHARM INC (US) 2007-12-19 CN disclosed
CN-1759095-A N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARM INC (US) 2006-04-12 CN disclosed
CN-1447789-A Compounds for treating alzheimer's disease ELAN PHARM INC (US) 2003-10-08 CN disclosed